CB
Live price temporarily unavailable.
Price history
Crescent Biopharma (CBIO) is a Health Care company in the Russell 2000. Latest news and coverage below.
Crescent Biopharma revenue & net income history (FY2016–FY2025)
RevenueNet income
| FY2016Dec 2016 | FY2017Dec 2017 | FY2018Dec 2018 | FY2019Dec 2019 | FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $18.5K | — | — | — | $10.2M | $1.16M | $75.0K | $10.0K | — | $10.8M |
| Growth (year over year) | −99.9% | — | — | — | — | −88.6% | −93.5% | −86.7% | — | — |
| Operating income | −$31.9M | −$33.9M | −$51.5M | −$61.4M | −$51.5M | −$63.4M | −$47.4M | −$39.3M | −$40.0M | −$152.6M |
| Operating margin | −172505.3% | — | — | — | −506.8% | −5470.7% | −63204.4% | −392752.9% | — | −1407.5% |
| Net income | −$31.8M | −$33.3M | −$48.3M | −$57.9M | −$51.0M | −$63.4M | −$46.7M | −$36.9M | −$37.9M | −$153.9M |
| Net margin | −171945.1% | — | — | — | −502.1% | −5469.0% | −62251.7% | −368994.2% | — | −1419.6% |
| EPS (diluted) | −$1.50 | −$1.13 | −$1.18 | −$1.34 | −$1.12 | −$1.23 | −$0.89 | −$0.58 | −$0.59 | — |
| Balance sheet | ||||||||||
| Cash and equivalents | $40.0M | $123.9M | $209.9M | $158.2M | $137.0M | $90.3M | $47.9M | $41.8M | $34.8M | $213.2M |
| Total assets | $42.4M | $128.6M | $214.8M | $168.0M | $142.8M | $94.3M | $51.8M | $45.3M | $35.6M | $240.3M |
| Total liabilities | $7.09M | $8.88M | $9.37M | $13.8M | $14.6M | $12.7M | $8.88M | $6.90M | $47.1M | $37.3M |
| Shareholders' equity | $35.3M | $119.7M | $205.5M | $154.2M | $128.2M | $81.6M | $42.9M | $38.4M | −$15.5M | $203.0M |
| Cash flow | ||||||||||
| Operating cash flow | −$29.7M | −$29.8M | −$43.3M | −$52.0M | −$39.2M | −$57.5M | −$46.5M | −$34.9M | −$31.1M | −$71.5M |
| Capital expenditure | $704.2K | $294.1K | $125.6K | $144.9K | $68.5K | $14.9K | $84.2K | $21.4K | $9.97K | $919.0K |
| Free cash flow | −$30.4M | −$30.1M | −$43.5M | −$52.1M | −$39.3M | −$57.5M | −$46.5M | −$34.9M | −$31.1M | −$72.5M |
RevenueNet income
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | — | — | $0 | $0 | — | — | $1.04M | $0 |
| Operating income | −$11.2M | −$7.33M | −$14.2M | −$21.0M | −$25.9M | −$91.5M | −$24.7M | −$26.4M |
| Operating margin | — | — | — | — | — | — | −2380.1% | — |
| Net income | −$9.82M | −$7.22M | −$15.1M | −$21.8M | −$24.6M | −$92.4M | −$23.3M | −$24.8M |
| Net margin | — | — | — | — | — | — | −2240.9% | — |
| EPS (diluted) | −$0.15 | −$0.24 | — | — | — | — | — | — |
| Balance sheet | ||||||||
| Cash and equivalents | $14.4M | $34.8M | $22.4M | $152.6M | $133.3M | $213.2M | $189.2M | $171.6M |
| Total assets | $15.7M | $35.6M | $5.99M | $157.4M | $138.3M | $240.3M | $199.1M | $182.8M |
| Total liabilities | $4.32M | $47.1M | $2.62M | $18.2M | $21.6M | $37.3M | $15.3M | $19.5M |
| Shareholders' equity | −$1.30M | −$15.5M | −$30.2M | $139.3M | $116.6M | $203.0M | $183.8M | $163.3M |
| Cash flow | ||||||||
| Operating cash flow | −$7.99M | −$3.70M | −$10.9M | −$16.4M | −$17.5M | −$26.7M | −$8.94M | −$19.5M |
| Capital expenditure | $0 | $0 | $0 | $140.0K | $586.0K | $193.0K | $147.0K | $13.0K |
| Free cash flow | −$7.99M | −$3.70M | −$10.9M | −$16.5M | −$18.1M | −$26.9M | −$9.08M | −$19.5M |
From Crescent Biopharma's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
About Crescent Biopharma
- Headquarters
- Waltham, Massachusetts From SEC filings, Oct 2026
Recent News (1)
Other Health Care companies to compare with CBIO
- CAMP CAMP4 THERAPEUTICS
- CAPR Capricor Therapeutics Inc
- CARL Carlsmed Inc
- CATX Perspective Therapeutics Inc
- CBLL Ceribell Inc
- CCCC C4 Therapeutics
- CCRN Cross Country Healthcare Inc
- CDNA Caredx Inc